Basic Information

Gene symbol CXCL12 Synonyms IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1 Type of gene protein-coding
Gene perturbation-related omics dataset PerturbAtlas | PertOrg
Description C-X-C motif chemokine ligand 12

GTO ID GTC1403
Trial ID NCT01486797
Disease Chronic Lymphocytic Leukemia
Altered gene CXCL-12
Therapeutic/Target gene Target gene
TherapyAptamer
Treatment NOX-A12|olaptesed pegol
PhasePhase2
Recruitment statusCompleted
TitleA Multi-center, Open Label, Uncontrolled, Phase IIA Clinical Trial Evaluating the Safety and Efficacy of NOX A12 in Combination With a Background Therapy of Bendamustine and Rituximab (BR) in Previously Treated Patients With Chronic Lymphocytic Leukemia (CLL)
Year2012
CountryAustria|Belgium|France|Italy
Company sponsorTME Pharma AG
Other ID(s)SNOXA12C201|2011-004672-11

Clinical Result

Cohort1: NOX-A12_dose level1
Administration route intravenous injection
Dosage NOX-A12, single dose, 1 mg/kg, 2 weeks
Age Adult, Older_Adult
References PMID: 31097627
Cohort2: NOX-A12_dose level2
Administration route intravenous injection
Dosage NOX-A12, single dose, 2 mg/kg, 2 weeks
Age Adult, Older_Adult
References PMID: 31097627
Cohort3: NOX-A12_dose level3
Administration route intravenous injection
Dosage NOX-A12, single dose, 4 mg/kg, 2 weeks
Age Adult, Older_Adult
References PMID: 31097627
Cohort4: NOX-A12_BR
Administration route intravenous injection
Dosage NOX-A12, 1 mg/kg(cycle 1), 2 mg/kg (cycle 2), 4 mg/kg (cycle 3)
Age Adult, Older_Adult
References PMID: 31097627

Relationship Graph

Overview of Knowledge Graph